noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

U.S. Naval Research Laboratory

Naval Research Laboratory Robotic Servicing Payload Clears Thermal[...]
Squarespace Inc.

Evolving Squarespace for Pros: A New Era for Creative Professionals
City of New Brunswick, NJ

New Brunswick Tomorrow Offers Free Financial Series

Healthcare

Nuwellis Inc.

09/18/2025 | Press release | Distributed by Public on 09/18/2025 07:18

Material Event (Form 8-K)

Item 8.01.

Other Events.

On September 18, 2025, Nuwellis, Inc. (the "Company") announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,415,021 on September 16, 2025, based on Application No. 18/298,860. The patent relates to the use of one or more hemolysis sensors with extracorporeal blood filtration systems-such as ultrafiltration therapy and continuous renal replacement therapy (CRRT)-to help detect and localize red blood cell destruction occurring within or around the circuit. The intellectual property supports the Company's pediatric device, Vivian, in development and future platform innovation.

Nuwellis Inc. published this content on September 18, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 18, 2025 at 13:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]